Clinical implications of neoadjuvant chemotherapy in advanced endometrial cancer: a multi-center retrospective cohort study

Table 6 Clinicopathologic variables associated with overall survival

Variables	Univariate analysis
Variables	HR	95% CI	*P-value*
Histology
Non-endometrioid vs. endometrioid	4.523	1.137–17.993	0.032
CA-125 at diagnosis, IU/ml
≥190 vs. <190	1.965	0.568–6.796	0.286
Residual tumor after IDS
Any RT vs. NGR	2.738	0.754–9.945	0.126

Abbreviations: FIGO International Federation of Gynecology and Obstetrics, IDS Interval debulking surgery, RT residual tumor, NGR no gross residual, HR hazard ratio, 95% CI 95% confidence interval

ISSN: 1471-2407